Literature DB >> 27416847

The interleukin-6-hepcidin-hemoglobin circuit in systemic lupus erythematosus flares.

D L Indrakanti1, A Alvarado1, X Zhang1, D J Birmingham1, A Hinton2, B H Rovin1.   

Abstract

Objective Hepcidin regulates iron availability and may be responsible for the anemia of chronic disease because it is induced by interleukin-6. This study investigated the IL-6-hepcidin-hemoglobin axis in patients with lupus. Methods IL-6 and hepcidin were measured in serial serum samples collected before, during and after lupus flares by specific ELISAs. Results During renal and non-renal SLE flare cycles IL-6 did not predict hepcidin and hepcidin did not predict hemoglobin. When lupus nephritis patients were in remission, IL-6 and hepcidin were correlated, but hepcidin and hemoglobin were not. Conclusion Hepcidin does not contribute significantly to anemia during active lupus.

Entities:  

Keywords:  Hepcidin; anemia; inflammation; lupus nephritis

Mesh:

Substances:

Year:  2016        PMID: 27416847      PMCID: PMC5237426          DOI: 10.1177/0961203316659153

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  16 in total

Review 1.  Anemia of chronic disease.

Authors:  Guenter Weiss; Lawrence T Goodnough
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

2.  Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.

Authors:  Elizabeta Nemeth; Erika V Valore; Mary Territo; Gary Schiller; Alan Lichtenstein; Tomas Ganz
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

3.  Regulation of hepcidin transcription by interleukin-1 and interleukin-6.

Authors:  Pauline Lee; Hongfan Peng; Terri Gelbart; Lei Wang; Ernest Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

4.  Urine chemokines as biomarkers of human systemic lupus erythematosus activity.

Authors:  Brad H Rovin; Huijuan Song; Dan J Birmingham; Lee A Hebert; Chack Yung Yu; Haikady N Nagaraja
Journal:  J Am Soc Nephrol       Date:  2004-12-15       Impact factor: 10.121

5.  Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease.

Authors:  Leida Tandara; Tihana Zanic Grubisic; Gudelj Ivan; Zrinka Jurisic; Marijan Tandara; Katarina Gugo; Suzana Mladinov; Ilza Salamunic
Journal:  Clin Biochem       Date:  2015-07-09       Impact factor: 3.281

6.  A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies.

Authors:  Xiaolan Zhang; Haikady N Nagaraja; Tibor Nadasdy; Huijuan Song; Alison McKinley; Jason Prosek; Swapna Kamadana; Brad H Rovin
Journal:  Kidney Int       Date:  2011-10-12       Impact factor: 10.612

7.  A study of hepcidin and monocyte chemoattractant protein-1 in Egyptian females with systemic lupus erythematosus.

Authors:  Moataz Fatthy Mohammed; Dawlat Belal; Seham Bakry; Mohamed A Marie; Laila Rashed; Reham Emad Eldin; Samah Abd El-Hamid
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

Review 8.  Beyond anemia: hepcidin, monocytes and inflammation.

Authors:  Xiaolan Zhang; Brad H Rovin
Journal:  Biol Chem       Date:  2013-02       Impact factor: 3.915

9.  Autocrine formation of hepcidin induces iron retention in human monocytes.

Authors:  Igor Theurl; Milan Theurl; Markus Seifert; Sabine Mair; Manfred Nairz; Holger Rumpold; Heinz Zoller; Rosa Bellmann-Weiler; Harald Niederegger; Heribert Talasz; Günter Weiss
Journal:  Blood       Date:  2007-12-11       Impact factor: 22.113

10.  Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney disease.

Authors:  Kakuya Niihata; Naohisa Tomosugi; Takuya Uehata; Tatsuya Shoji; Kensuke Mitsumoto; Morihiro Shimizu; Hiroaki Kawabata; Yusuke Sakaguchi; Akira Suzuki; Terumasa Hayashi; Noriyuki Okada; Yoshitaka Isaka; Hiromi Rakugi; Yoshiharu Tsubakihara
Journal:  Nephrol Dial Transplant       Date:  2012-07-24       Impact factor: 5.992

View more
  3 in total

1.  Hepcidin in Kawasaki disease: upregulation by acute inflammation in patients having resistance to intravenous immunoglobulin therapy.

Authors:  Takashi Ishikawa; Yasuyuki Wada; Hiroyuki Namba; Toshinao Kawai
Journal:  Clin Rheumatol       Date:  2021-06-19       Impact factor: 2.980

Review 2.  Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis.

Authors:  Ewa Wlazlo; Borna Mehrad; Laurence Morel; Yogesh Scindia
Journal:  Front Med (Lausanne)       Date:  2021-04-12

Review 3.  Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus.

Authors:  Chris Wincup; Natalie Sawford; Anisur Rahman
Journal:  Expert Rev Clin Immunol       Date:  2021-07-30       Impact factor: 4.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.